Poll: How Much Do You Know About Biosimilar Suffixes?


Biosimilar suffixes were intended to help with pharmacovigilance, but they are not widely understood.

Which of the following is true about the 4-letter biosimilar suffixes?

Each is an abbreviation of the biosimilar brand name.
Suffixes are deliberately random and nonsensical.
They signify key differences between biosimilars and originator brands.
Physicians prefer using suffixes rather than brand names.

For background reading on this topic, click here.

Check out the results from our last poll:

Related Videos
Fran Gregory, PharmD, MBA
 Fran Gregory, PharmD, vice president of emerging therapies, Cardinal Health.
Fran Gregory, PharmD, vice president of emerging therapies at Cardinal Health
Michael Kleinrock
Here are the top 5 biosimilar articles for the week of February 13th, 2023.
Michael Kleinrock
Ian Henshaw
Ryan Haumschild, PharmD
Ryan Haumschild, PharmD, MS, MBA
Ryan Haumschild, PharmD
Related Content
© 2023 MJH Life Sciences

All rights reserved.